PHOSPHATE WASTING IN FIBROUS DYSPLASIA
813
2. Dorfman HD, Czerniak B 1998 Fibroosseous Lesions. In: 23. Drezner MK 1984 The role of abnormal vitamin D metabolism
Czerniak B, Dorfman HD (eds.) Bone Tumors. Mosby, St.
Louis, MO, USA, pp. 441–491.
in X-linked hypophosphatemic rickets and osteomalacia. Adv
Exp Med Biol 178:399–404.
3. Albright F, Butler A, Hampton A, Smith P 1937 Syndrome 24. Brewer E 1985 The Fanconi syndrome: Clinical disorders. In:
characterized by osteitis fibrosa disseminata, areas, of pigmen-
tation, and endocrine dysfunction, with precocious puberty in
females: Report of 5 cases. N Engl J Med 216:727–746.
4. Ringel MD, Schwindinger WF, Levine MA 1996 Clinical
implications of genetic defects in G proteins. The molecular
basis of McCune-Albright syndrome and Albright hereditary
osteodystrophy. Medicine (Baltimore) 75:171–184.
Buckalew VM, Gonick HC (eds.) Renal Tubular Disorders.
Marcel Dekker, New York, NY, USA, pp. 475–544.
25. Bianco P, Riminucci M, Majolagbe A, Kuznetsov SA, Collins
MT, Mankani MH, Corsi A, Bone HG, Wientroub S, Spiegel
AM, Fisher LW, Robey PG 2000 Mutations of the GNAS1
gene, stromal cell dysfunction, and osteomalacic changes in
non-McCune-Albright fibrous dysplasia of bone. J Bone Miner
Res 15:120–128.
5. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman
E, Spiegel AM 1991 Activating mutations of the stimulatory G 26. Pyle SI, Waterhouse AM, Greulich WW 1971 Attributes of the
protein in the McCune-Albright syndrome. N Engl J Med
radiographic standard of reference for the National Health
325:1688–1695.
Examination Survey. Am J Phys Anthropol 35:331–337.
6. Schwindinger WF, Francomano CA, Levine MA 1992 Identi- 27. Walton RJ, Bijvoet OL 1977 A simple slide-rule method for
fication of a mutation in the gene encoding the alpha subunit of
the stimulatory G protein of adenylyl cyclase in McCune-
Albright syndrome. Proc Natl Acad Sci USA 89:5152–5156.
7. Spiegel AM 1997 Inborn errors of signal transduction: Muta-
tions in G proteins and G protein-coupled receptors as a cause
of disease. J Inherit Metab Dis 20:113–121.
8. Happle R 1986 The McCune-Albright syndrome: A lethal
gene surviving by mosaicism. Clin Genet 29:321–324.
9. Spada A, Vallar L 1992 G-protein oncogenes in acromegaly.
Horm Res 38:90–93.
the assessment of renal tubular reaborption of phosphate in
man. Clin Chim Acta 81:273–276.
28. Payne RB 1998 Renal tubular reabsorption of phosphate
(TmP/GFR): Indications and interpretation. Ann Clin Biochem
35:201–206.
29. Slocum RH, Cummings JG 1991 Amino acid analysis of
physiological samples. In: Hommes FA (ed.) Techniques in
Diagnostic Human Biochemical Genetics, Wiley-Liss, New
York, NY, USA, pp. 87–126.
30. Gray RW, Wilz DR, Caldas AE, Lemann J Jr 1977 The
importance of phosphate in regulating plasma 1,25-(OH)2-
vitamin D levels in humans: Studies in healthy subjects in
calcium-stone formers and in patients with primary hyperpara-
thyroidism. J Clin Endocrinol Metab 45:299–306.
10. Halvorsen S, Aas K 1961 Renal tubular defects in fibrous
dysplasia of bones: Report of two cases. Acta Paediatr Scand
50:297–303.
11. Ryan WG, Nibbe AF, Schwartz TB, Ray RD 1968 Fibrous
dysplasia of bone with vitamin D resistant rickets: A case 31. Juppner HBE, Kronenberg HM 1999 Parathyroid hormone. In:
study. Metabolism 17:988–998.
12. Grubbauer HM, Stogmann W, Messner H 1974 Studies of
Favus MJ (ed.) Primer on the Metabolic Bone Diseases. Lippin-
cott Williams & Wilkins, Philadelphia, PA, USA, pp. 80–87.
calcium phosphate metabolism in a case of McCune-Albright 32. Broadus AE 1979 Nephrogenous cyclic AMP as a parathyroid
syndrome with phosphate diabetes (author’s translation). Z
Kinderheilkd 117:47–61.
13. Dent CE, Gertner JM 1976 Hypophosphataemic osteomalacia
in fibrous dysplasia. QJM 45:411–420.
function test. Nephron 23:136–141.
33. Drezner MK 2000 PHEX gene and hypophosphatemia. Kidney
Int 57:9–18.
34. Phillips ME 1980 Aminoaciduria—its relationship to vitamin D
and parathyroid hormone. Crit Rev Clin Lab Sci 12:215–239.
14. Tanaka T, Suwa S 1977 A case of McCune-Albright syndrome
with hyperthyroidism and vitam D-resistant reckets. Helv Pae- 35. Rasmussen H, Anast C 1983 Familial hypophophatemic rick-
diatr Acta 32:263–273.
ets and vitamin D-dependent rickets. In: Stanbury JB, Wyn-
gaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds.)
The Metabolic Basis of Inherited Diseases. McGraw-Hill,
New York, NY, USA, pp. 1743–1773.
15. McArthur RG, Hayles AB, Lambert PW 1979 Albright’s syn-
drome with rickets. Mayo Clin Proc 54:313–320.
16. Lever EG, Pettingale KW 1983 Albright’s syndrome associ-
ated with a soft-tissue myxoma and hypophosphataemic os- 36. Econs MJ, McEnery PT, Lennon F, Speer MC 1997 Autoso-
teomalacia. Report of a case and review of the literature.
mal dominant hypophosphatemic rickets is linked to chromo-
J Bone Joint Surg Br 65:621–626.
some 12p13. J Clin Invest 100:2653–2657.
17. Dachille RD, Goldberg JS, Wexler ID, Shons AR 1990 Fi- 37. Chapurlat RD, Delmas PD, Liens D, Meunier PJ 1997 Long-
brous dysplasia-induced hypocalcemia/rickets. J Oral Maxil-
lofac Surg 48:1319–1322.
term effects of intravenous pamidronate in fibrous dysplasia of
bone. J Bone Miner Res 12:1746–1752.
18. Lee SH, Sanderson J 1989 Hypophosphataemic rickets and
melorheostosis. Clin Radiol 40:209–211.
19. Zung A, Chalew SA, Schwindinger WF, Levine MA, Phillip
M, Jara A, Counts DR, Kowarski AA 1995 Urinary cyclic
adenosine 3Ј,5Ј-monophosphate response in McCune-Albright
syndrome: Clinical evidence for altered renal adenylate cy-
clase activity. J Clin Endocrinol Metab 80:3576–3581.
20. Whyte M 1996 Hypophosphatemic bone disease in McCune-
Albright syndrome. Calcif Tissue Int 59:224.
Address reprint requests to:
Michael T. Collins
Craniofacial and Skeletal Diseases Branch
National Institute of Dental and Craniofacial Research
National Institutes of Health
Building 30, Room 228
21. Drezner MK, Feinglos MN 1977 Osteomalacia due to
1alpha,25-dihydroxycholecalciferol deficiency. Association
with a giant cell tumor of bone. J Clin Invest 60:1046–1053.
22. Kumar R 1997 Phosphatonin—a new phosphaturetic hor-
mone? (Lessons from tumour-induced osteomalacia and
MSC 4320
Bethesda, MD 20892-4320, USA
X-linked hypophosphataemia.) Nephrol Dial Transplant 12: Received in original form August 16, 2000; in revised form No-
11–13 (editorial). vember 16, 2000; accepted December 6, 2000.